Dr. David M Waterhouse
Claim this profileOncology Hematology Care
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
7 reported clinical trials
15 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
EGFR negative
2Lung Cancer
Stage III
Stage IV
EGFR negative
Affiliated Hospitals
Clinical Trials David M Waterhouse is currently running
Brentuximab Vedotin + Pembrolizumab
for Advanced Cancers
This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer. There will be several different types of cancer studied in the trial. The cancer must have spread to other parts of the body (metastatic). The study will also find out what side effects occur. A side effect is anything the treatment does besides treat cancer. This is a multi-cohort study.
Recruiting1 award Phase 27 criteria
Sigvotatug Vedotin vs Docetaxel
for Lung Cancer
This trial is testing a new drug, sigvotatug vedotin, against a standard drug, docetaxel, in patients with advanced lung cancer. The goal is to see if the new drug works better and to understand its side effects. Docetaxel (Taxotere) is a well-established chemotherapy agent used in the treatment of advanced non-small cell lung cancer (NSCLC), often after failure of first-line treatments.
Recruiting2 awards Phase 35 criteria
More about David M Waterhouse
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments David M Waterhouse has experience with
- Pembrolizumab
- Nivolumab
- Dostarlimab
- Pemetrexed
- Cisplatin
- Carboplatin
Breakdown of trials David M Waterhouse has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David M Waterhouse specialize in?
David M Waterhouse focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is David M Waterhouse currently recruiting for clinical trials?
Yes, David M Waterhouse is currently recruiting for 3 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that David M Waterhouse has studied deeply?
Yes, David M Waterhouse has studied treatments such as Pembrolizumab, Nivolumab, Dostarlimab.
What is the best way to schedule an appointment with David M Waterhouse?
Apply for one of the trials that David M Waterhouse is conducting.
What is the office address of David M Waterhouse?
The office of David M Waterhouse is located at: Oncology Hematology Care, Cincinnati, Ohio 45242 United States. This is the address for their practice at the Oncology Hematology Care.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.